Commence Bio
Sparks Glencoe
About Commence Bio
Commence Bio is a therapeutics company developing methods to improve the anti-inflammatory properties of stem cells. Commence aims to apply these methods in various inflammation-related disorders, including rheumatoid arthritis, by creating uniform cellular therapeutics with predictable behaviors.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $400.0K
- Last round: Grant (Oct 2012)
- Website: commencebio.com
- Phone: 443-955-4262
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/commence-bio-3081166 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.